Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Utilizing the Nu.Q® Vet Cancer Test in Your Practice Webinar

Friday, June 27, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The upcoming webinar on the Nu.Q® Vet Cancer Test will feature Dr. Tom Butera, CEO of Volition Veterinary. He will address challenges in diagnosing canine cancer and share recent clinical data. The session aims to provide practical advice for integrating the test into veterinary practices.
Price reaction · baseline $16.998 (2025-06-27T14:34:00.000Z) · hit during market hours · 1 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
-1.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Webinar provides practical guidance for veterinary practices.
  • Dr. Tom Butera shares insights on canine cancer diagnosis.
  • Recent clinical data supports the effectiveness of the test.

Full Press Release Details

Utilizing the Nu.Q ® Vet Cancer Test in Your Practice

Discover how the Nu.Q ® Vet Cancer Test can enhance your clinical practice in this webinar. Dr. Tom Butera, CEO of Volition Veterinary, explores common challenges in canine cancer diagnosis, reviews recent clinical data, and provides practical guidance on integrating this innovative test into your daily workflow.

Watch Here

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the focus of the Nu.Q® Vet Cancer Test webinar?

The webinar focuses on enhancing clinical practices using the Nu.Q® Vet Cancer Test.

Who is presenting the webinar on the Nu.Q® Vet Cancer Test?

Dr. Tom Butera, CEO of Volition Veterinary, will present the webinar.

What will be discussed in the webinar?

The webinar will cover challenges in canine cancer diagnosis and recent clinical data.

How can the Nu.Q® Vet Cancer Test be integrated into practice?

The webinar will provide practical guidance on integrating the test into daily workflows.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare canine cancer veterinary practice clinical data webinar
Last updated: Jun 27, 2025

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk